Long-term antibiotic therapy for balanitis xerotica obliterans
Tóm tắt
Từ khóa
Tài liệu tham khảo
Laymon, 1994, Relationship of balanitis xerotica obliterans to lichen sclerosus et atrophicus, Arch Dermatol Syphilol, 49, 57, 10.1001/archderm.1944.01510070060010
Prede, 1993, Penile squamous cell carcinoma arising from balanitis xerotica obliterans, J Am Acad Dermatol, 29, 469, 10.1016/0190-9622(93)70213-D
Shelley, 1987, Advanced dermatologic therapy, 94
Bale, 1987, Balanitis xerotica obliterans in children, Pediatr Pathol, 7, 617, 10.3109/15513818709161425
1997, 243
Hinman, 1998, Atlas of urologic surgery, 266
Schempp, 1993, Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification, J Invest Dermatol, 100, 717, 10.1111/1523-1747.ep12472369
Aberer, 1998, Neuroborreliosis in morphea and lichen sclerosus et atrophicus, J Am Acad Dermatol, 19, 820, 10.1016/S0190-9622(88)70239-X
Weber, 1998, Spirochetes isolated from two patients with morphea, Infection, 16, 25, 10.1007/BF01646925
Uitto, 1980, Morphea and lichen sclerosus et atrophicus: clinical and histopathologic studies in patients with combined features, J Am Acad Dermatol, 3, 271, 10.1016/S0190-9622(80)80190-3
Duray, 1978, Clinical pathologic correlations of Lyme disease by stage, Ann NY Acad Sci, 539, 65, 10.1111/j.1749-6632.1988.tb31839.x
Malane, 1991, Diagnosis of Lyme disease based on dermatologic manifestations, Ann Intern Med, 114, 490, 10.7326/0003-4819-114-6-490
Aberer, 1987, Acrodermatitis chronica atrophicans in association with lichen sclerosus et atrophicans: tubulo-interstitial nephritis and urinary excretion of spirochete-like organisms, Acta Derm Venereol (Stockh), 67, 62, 10.2340/00015555676265
Duray, 1989, The cutaneous manifestations of human Lyme disease: a widening spectrum, Adv Dermatol, 4, 255
Thyresson, 1949, The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer), Acta Derm Venereol (Stockh), 29, 572
Asbrink, 1984, The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer, Acta Derm Venereol (Stockh), 64, 506, 10.2340/0001555564506512
Aberer, 1991, Borrelia burgdorferi and different types of morphea, Dermatologica, 182, 145, 10.1159/000247767
Schwan, 1988, The urinary bladder, a consistent source of Borrelia burgdorferi in experimentally infected white-foot mice (Peromyscus leucopus), J Clin Microbiol, 26, 893, 10.1128/JCM.26.5.893-895.1988
Ledwig, 1989, Late circumcision and lichen sclerosus et atrophicus of the penis, J Am Acad Dermatol, 20, 211, 10.1016/S0190-9622(89)70024-4
Tuffanelli, 1993, False-positive Lyme antibody test in morphea, J Am Acad Dermatol, 28, 112, 10.1016/S0190-9622(08)80848-1
Meis, 1993, No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea), Arch Dermatol, 129, 386, 10.1001/archderm.1993.01680240132029
Raguin, 1992, No evidence for a spirochaetal origin of localized scleroderma, Br J Dermatol, 127, 218, 10.1111/j.1365-2133.1992.tb00117.x
Stanek, 1985, Differences between Lyme disease and European arthropod-borne Borrelia infections [letter], Lancet, 1, 401, 10.1016/S0140-6736(85)91424-2
Dressler, 1994, Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis, J Infect Dis, 169, 313, 10.1093/infdis/169.2.313
Hashimoto, 1995, Lyme disease in Japan: analysis of Borrelia species using r RNA gene restruction fragment length polymorphism, Dermatologica, 191, 193, 10.1159/000246545
Hyde, 1989, Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease, J Clin Microbiol, 27, 56, 10.1128/JCM.27.1.58-61.1989
Goodman, 1991, Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease, Infect Immun, 59, 269, 10.1128/IAI.59.1.269-278.1991
Sigal, 1997, Lyme disease: a review of aspects of its immunology and immunopathogenesis, Ann Immunol, 15, 63, 10.1146/annurev.immunol.15.1.63
Georgilis, 1992, Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro, J Infect Dis, l66, 440, 10.1093/infdis/166.2.440
Ma, 1991, Intracellular localization of Borrelia burgdorferi within human endothelial cells, Infect Immun, 59, 671, 10.1128/IAI.59.2.671-678.1991
Montgomery, 1993, The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages, J Immunol, 150, 909, 10.4049/jimmunol.150.3.909
Hauser, 1984, Effect of antimicrobial agents on the immune response, 55
Vazquez, 1975, The macrolide antibiotics, 459